Aslan Fred sold ARTV
October 6, 2026 · Form 4 insider transaction
Aslan Fred sold 23,463 shares of Artiva Biotherapeutics, Inc. at $7.20 per share, a transaction worth $168.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
23,463
Price
$7.20
Total value
$168.9K
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 6, 2026
Filing dateOctober 7, 2026
Shares owned after1,519,606
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 13, 2026.; The weighted average sale price for the transaction reported was $7.1977, and the range of prices were between $6.92 and $7.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.